Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma (Q38399886)

2 September 2017

Role of platelet derived growth factor receptor (PDGFR) over-expression and angiogenesis in ependymoma (English)

1 reference

2 September 2017

5

Chris Jones

1 reference

2 September 2017

Lucas Moreno

1

1 reference

2 September 2017

Sergey Popov

2

1 reference

2 September 2017

Alexa Jury

3

1 reference

2 September 2017

Saffa Al Sarraj

4

1 reference

2 September 2017

Stergios Zacharoulis

6

1 reference

2 September 2017

language of work or name

1 reference

8 November 2012

1 reference

Journal of Neuro-Oncology

2 September 2017

1 reference

2 September 2017

111

1 reference

2 September 2017

2

1 reference

2 September 2017

169-176

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-012-0996-z

2 September 2017

0 references

cites work

Ependymoma: an update

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Pediatric intracranial ependymoma: the roles of surgery, radiation and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Intracranial ependymoma: factors affecting outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Treatment and outcome of children with relapsed ependymoma: a multi-institutional retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Three-dimensional (3D) reconstruction and quantitative analysis of the microvasculature in medulloblastoma and ependymoma subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Tumor vessel biology in pediatric intracranial ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Vascularization and expression of hypoxia-related tissue factors in intracranial ependymoma and their impact on patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Expression of vascular endothelial growth factor and its receptors in the anaplastic progression of astrocytoma, oligodendroglioma, and ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Bevacizumab for recurrent ependymoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

CD105 expression is an independent predictor of survival in patients with endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Endoglin (CD105): a target for anti-angiogenetic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Early contribution of pericytes to angiogenic sprouting and tube formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Recent insights into PDGF-induced gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Expression of platelet-derived growth factor transcripts in medulloblastomas and ependymomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Recurrent spinal ependymoma showing partial remission under Imatimib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11060-012-0996-Z

Requisite role of VEGF receptors in angiogenesis of hepatocellular carcinoma: a comparison with angiopoietin/Tie pathway

21 January 2018

1 reference

12 December 2020

CD105 expression is a marker of high metastatic risk and poor outcome in breast carcinomas. Correlations between immunohistochemical analysis and long-term follow-up in a series of 929 patients

1 reference

12 December 2020

Endoglin (CD105) expression in endometrial carcinoma

1 reference

12 December 2020

Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.

1 reference

12 December 2020

Endoglin (CD105) as a prognostic factor in head and neck squamous cell carcinoma

1 reference

12 December 2020

High expression of CD105 as a prognostic predictor of early tongue cancer

1 reference

12 December 2020

10.1007/S11060-012-0996-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference